Prostate cancer care has seen tremendous advances over the last ten years. As urologists, we have become more thoughtful about the over treatment of low grade cancers and new technologies such as MRI have given us tools to better risk stratify patients and offer surveillance to more patients. A fascinating new multi-institutional study from Europe, the PRECISION trial, found that MRI prior to biopsy of the prostate for cancer detection is superior to standard ultrasound-guided biopsy among men at risk for prostate cancer, published in the New England Journal of Medicine.
Read More